Cart (0 Items)
Your cart is currently empty.
View ProductsSize | |
---|---|
Brand | |
Product type | |
Clonality | |
Expression system | |
Applications |
Product name | Certolizumab Biosimilar - Anti-TNF-Alpha mAb - Research Grade |
---|---|
Source | DrugBank DB08904 |
Species | Human |
Expression system | Mammalian cells |
Molecular weight | 45kDa |
Purity | >85% |
Buffer | PBS pH7.5 |
Delivery condition | Blue ice (+4°C) |
Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
Storage condition | 4°C for short term; -20°C for long term |
Brand | ProteoGenix |
Applications | ELISA,WB |
Aliases /Synonyms | Certolizumab,Certolizumab,TNF-Alpha,anti-TNF-Alpha |
Reference | PX-TA1024 |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Isotype | Fab'G1Kappa |
Clonality | Monoclonal Antibody |
Immobilized Human TNFa Recombinant Protein (cat. No. PX-P3058) at 0.5µg/mL (100µL/well) can bind Certolizumab Biosimilar - Anti-TNF-Alpha mAb (cat. No. PX-TA1024) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450 giving an EC50 at 105.9M.
Certolizumab Biosimilar - Anti-TNF-Alpha mAb, on SDS-PAGE under non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Related products
Reviews
Il n’y a pas encore d’avis.